CRISPR-powered Biosensing Platform for Quantitative Detection of Alpha-fetoprotein by a Personal Glucose Meter.

Jia, Zhengyang; Li, Ziyue; Liu, Changchun

Jia, Zhengyang; Li, Ziyue; Liu, Changchun.

Afiliación

Jia Z; Department of Biomedical Engineering, University of Connecticut Health Center, Farmington, CT 06030, United States.
Li Z; Department of Biomedical Engineering, University of Connecticut Health Center, Farmington, CT 06030, United States.
Liu C; Department of Biomedical Engineering, University of Connecticut, Storrs, CT 06269, United States.

Sens Actuators B Chem ; 3902023 Sep 01.

Article en En | MEDLINE | ID: mdl-37303825

Palabras clave

CRISPR-Cas12a assay; alpha-fetoprotein detection; aptamer; personal glucose meter; point-of-care diagnosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Sens Actuators B Chem Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google